Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 9;10:4288. doi: 10.1038/s41598-020-61004-3

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Graphic illustration of the experimental design and procedure. Participants were subjected to four sessions. At session 1, participants completed the DASS²³, the Mini-DIPS²⁴ and the fear conditioning task¹⁹. At the end of the session, participants received information about the exposure treatment, psychoeducation about spider phobia, and filled in the spider-fear related questionnaires (#1). At session 2 (conducted approx. 1 week later), participants received instructions on the BAT and were familiarized with the SUDS. Participants then completed the first BAT (#1), after which the first exposure session was conducted. Approx. 2-3 days later, at session 3, the second exposure session was conducted, followed by a short rehearsal of BAT instructions and the completion of the BAT (#2) and the spider-fear related questionnaires (#2). The follow-up assessment (session 4) was conducted approximately six weeks later. Here, the BAT (#3) was conducted in both the treatment context as well as in a novel context (BAT #4), with a randomized order of context presentation. At the end of session 4, the spider-fear related questionnaires (#3) were completed and participants were fully debriefed. DASS Items: Depression Anxiety Stress Scales²³.